Michael Schlabach Email

VP, Target Discovery . KSQ Therapeutics

Current Roles

Employees:
78
Revenue:
$15.7M
About
KSQ Therapeutics has built an industry-leading genome-scale precision functional genomics platform, called CRISPRomics, to pinpoint therapeutic nodes that directly correlate genomic function to disease with unprecedented certainty and speed. The company is deploying CRISPRomics for novel drug development across broad therapeutic areas and is currently advancing a proprietary pipeline of tumor- and immune-focused drug candidates. KSQ was founded by thought leaders in the field of functional genomics and pioneers of CRISPR screening technologies, and the company is located in Cambridge, Massachusetts. For more information, please visit the company's website at www.ksqtx.com.
KSQ Therapeutics Address
610 Main Street North
Cambridge, MA
United States

Past Companies

Curie.BioSVP, CSO Partner Team
KSQ Therapeutics, Inc.VP, Target Discovery
KSQ Therapeutics, Inc.Sr. Director, Target Discovery

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.